Ray Therapeutics

SAN FRANCISCO, CA · Founded 2021 · Biotech · Private

Optogenetic system that reprograms surviving retinal neurons to sense light and restore vision

Claim this profile

Follows are private to you and power your alerts

Updated · raytx.com

Sector
Biotech
Headquarters
SAN FRANCISCO, CA
Founded
2021
Latest Form D
$14M, May 2023
Total capital
$20M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$20M
2 Form D · last May 2023
41 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
4 pending

Capital timeline

20222023FEDERAL ↑EQUITY ↓Cumulative $20M1st Form D$6M2nd Form D$14M
20222023FEDERAL ↑EQUITY ↓Cumulative $20M1st Form D$6M2nd Form D$14M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$14M
  • Private capital raisedForm D · SEC · 1st filing$6M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Dmitry KuzminDirectorNamed in SEC Form D filings
  • Gary AbramsDirectorNamed in SEC Form D filings
  • Hannah ChangDirectorNamed in SEC Form D filings
  • Paul BresgeExecutive Officer, DirectorNamed in SEC Form D filings
  • Raymond CamahortDirectorNamed in SEC Form D filings
  • Sean AinsworthExecutive Officer, DirectorNamed in SEC Form D filings
Show all 7 people
  • Tiba AynechiDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 4
  • PendingMulti-luminance Mobility Test For The Assessment Of VisionUSPTOApplication PCTUS2025051356
  • PendingMulti-luminance Mobility Test For The Assessment Of VisionUSPTOApplication 63799090
  • PendingMultiluminence Mobility Test For The Assessment Of VisionUSPTOApplication 63709260
Show all 4 patent records
  • Multi-luminance Mobility Test For The Assessment Of VisionApplication PCTUS2025051356Pending
  • Multi-luminance Mobility Test For The Assessment Of VisionApplication 63799090Pending
  • Multiluminence Mobility Test For The Assessment Of VisionApplication 63709260Pending
  • Gene Therapy Compositions And Methods For Treating Diseases Of The RetinaApplication PCTUS2024016073Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .